$PLPL News- Plandai Biotechnology In Non-Binding
Post# of 75
(Total Views: 440)
Posted On: 05/25/2022 11:58:28 AM
$PLPL News- Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System ( FDA APPROVED ) with Plans to Address the International Blood Filtration Market
$PLPL FDA Approved (Puriblood in Taiwan has a market value of $65 million. And they only have Taiwan. $PLPL has all of North, Central and South America)
$FDA APPROVED #MONKEYPOX #COVID #COVID19 #BLOOD #VIRUS
https://www.accesswire.com/702221/Plandai-Bio...ion-Market
(0)
(0)Plandai Biotechnology Inc. (PLPL) Stock Research Links
Scroll down for more posts ▼